SOUTHLAKE, Texas–(BUSINESS WIRE)–HeartSciences, a medical device company developing next generation ECG devices using continuous wavelet transform (CWT) signal processing, is proud to announce its participation as an exhibitor at the upcoming 2018 Scientific Sessions of the American Heart Association (AHA). The AHA Congress will take place November 10-12, 2018 at […]
Tag: HeartSciences
HeartSciences Named Among ‘50 Smartest Companies of the Year 2018’ by The Silicon Review Magazine
SOUTHLAKE, Texas–(BUSINESS WIRE)–Silicon Review, a leading Business and Technology magazine has named HeartSciences, as one of the 50 Smartest Companies of the Year 2018. “The Silicon Review 50 Smartest Companies of the Year 2018 program identifies companies that mastered the discipline of smartness and stood high among the crowd,” said Sreshtha Banerjee, Editor-in-Chief […]
HeartSciences Showcases MyoVista® Wavelet ECG at 2018 European Society of Cardiology Congress (ESC)
SOUTHLAKE, Texas–(BUSINESS WIRE)–HeartSciences, a medical device company developing next generation ECG devices using continuous wavelet transform (CWT) signal processing and artificial intelligence, is proud to announce its participation as an exhibitor at the upcoming 2018 European Society of Cardiology Congress (ESC). The Congress will take place at Messe Munich International […]
HeartSciences Showcases MyoVista® Wavelet ECG at the 2018 International Congress on Electrocardiology (ICE)
SOUTHLAKE, Texas–(BUSINESS WIRE)–HeartSciences, an innovative medical device company, is proud to announce its participation as an exhibitor at the upcoming 2018 International Congress on Electrocardiology (ICE), which will be held in Makuhari Messe, Chiba City, Japan, June 28-30, 2018. ICE2018 will be the joint meeting of the 45th Congress of […]
Heart Sciences announces that Professor Peter McFarlane has been appointed to the clinical advisory committee
Southwest Texas South Lake – ( BUSINESS WIRE ) – ( BUSINESS WIRE ) – As a US-based medical equipment company, continuous wavelet transform (CWT) signal processing method and field of electrocardiogram inspection through application of artificial intelligence to lead the innovation in the heart Sciences today announced that it has welcomed Peter · W · McFarlane […]
HeartSciences Announces Professor Peter Macfarlane Joins Clinical Advisory Board
SOUTHLAKE, Texas–(BUSINESS WIRE)–HeartSciences, a U.S.-based medical device company that is leading innovation in the field of electrocardiology through the application of continuous wavelet transform (CWT) signal processing and artificial intelligence, announced today that Peter W. Macfarlane has joined its board of clinical advisors. Professor Peter W. Macfarlane, DSc eFESC FRSE, […]
HeartSciences Announces Publication of Clinical Trial Results in Journal of the American College of Cardiology (JACC)
SOUTHLAKE, Texas – ( BUSINESS WIRE ) – HeartSciences , a medical device company that is at the forefront of innovation in the field of electrocardiography thanks to the application of artificial intelligence and signal processing based on continuous waveforms (continuous wavelet transform, CWT), today announced the results of a clinical study conducted serially […]
HeartSciences Showcases MyoVista® Wavelet ECG at 2018 China International Medicinal Equipment Fair (CMEF)
SOUTHLAKE, Texas–(BUSINESS WIRE)–HeartSciences, an innovative medical device company, is proud to announce its participation as an exhibitor at the upcoming 2018 China International Medicinal Equipment Fair (CMEF) Shanghai, China, April 11-14, 2018. CMEF has become the largest fair of medical devices, related products and services in the Asia-Pacific region. The […]
HeartSciences Showcases High Sensitivity ECG at 2018 Arab Health Meeting
SOUTHLAKE, Texas–(BUSINESS WIRE)– HeartSciences, an innovative medical device company, is proud to announce its participation as an exhibitor at the upcoming 2018 Arab Health show at the Dubai International Convention and Exhibition Centre in Dubai, UAE, 29 January through 01 February, 2018. HeartSciences is advancing the field of electrocardiology in combining […]
HeartSciences Launches Breakthrough ECG Technology at the Canadian Cardiovascular Congress
MyoVista® hsECG™ Utilizes Wavelet Technology to Detect Cardiac Diastolic Dysfunction SOUTHLAKE, Texas, Oct. 19, 2017 /PRNewswire-USNewswire/ — HeartSciences announced today that the company will launch its MyoVista® high sensitivity electrocardiograph (hsECG™) Testing Device in Canada at the Canadian Cardiovascular Congress (CCC) in Vancouver on October 21-24. The MyoVista hsECG is now available in Canada, where it received Health Canada Medical […]